Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes

Journal of Allergy and Clinical Immunology

Volumn 131, Issue 2, 2013, Pages

  Roufosse, Florence E ^a   Kahn, Jean Emmanuel ^b   Gleich, Gerald J ^c   Schwartz, Lawrence B ^d   Singh, Anish D ^e   Rosenwasser, Lanny J ^f   Denburg, Judah A ^g   Ring, Johannes ^h   Rothenberg, Marc E ⁱ   Sheikh, Javed ^j   Haig, Ann E ^k   Mallett, Stephen A ^l   Templeton, Deborah N ^k   Ortega, Hector G ^k   Klion, Amy D ^m  

^a ERASME HOSPITAL   (Belgium)

^b FOCH HOSPITAL   (France)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^f UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^g MCMASTER UNIVERSITY   (Canada)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^k GLAXOSMITHKLINE   (United States)

^l GLAXOSMITHKLINE   (United Kingdom)

^m NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

corticosteroid; Eosinophil; interleukin 5; monoclonal antibody

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MEPOLIZUMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ABDOMINAL PAIN; ACUTE CHOLECYSTITIS; ADULT; AGED; ARTHRALGIA; ARTICLE; ASTHMA; CONTROLLED STUDY; COUGHING; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG EXPOSURE; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPNEA; DYSTHYMIA; EOSINOPHILIA; FEMALE; FEVER; HEART FAILURE; HUMAN; HYPEREOSINOPHILIC SYNDROME; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEPHROTIC SYNDROME; OPEN STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; TREATMENT DURATION; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION;

EID: 84873406289     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.07.055     Document Type: Article

References (14)

1. P. Valent, A.D. Klion, H.P. Horny, F. Roufosse, J. Gotlib, and P.F. Weller Contemporary consensus proposal on criteria and classification of eosinophil disorders and related syndromes J Allergy Clin Immunol 2012 [EPub ahead of print]
2. P.U. Ogbogu, B.S. Bochner, J.H. Butterfield, G.J. Gleich, J. Huss-Marp, and J.E. Kahn Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy J Allergy Clin Immunol 124 2009 1319 1325.e3
3. M.E. Rothenberg, A.D. Klion, F.E. Roufosse, J.E. Kahn, P.F. Weller, and H.U. Simon Treatment of patients with the hypereosinophilic syndrome with mepolizumab N Engl J Med 358 2008 1215 1228
4. Howlander N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975-2009- pops09/, based on November 2011 SEER data submission, posted to the SEER Web site, April 2012.
5. P. Gevaert, N. Van Bruaene, T. Cattaert, K. Van Steen, T. Van Zele, and F. Acke Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis J Allergy Clin Immunol 128 2011 989 995.e8
6. P. Haldar, C.E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, and A. Sousa Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
7. P. Nair, M.M. Pizzichini, M. Kjarsgaard, M.D. Inman, A. Efthimiadis, and E. Pizzichini Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N Engl J Med 360 2009 985 993
8. H.U. Simon, S.G. Plotz, R. Dummer, and K. Blaser Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia N Engl J Med 341 1999 1112 1120
9. F. Roufosse, E. Cogan, and M. Goldman Lymphocytic variant hypereosinophilic syndromes Immunol Allergy Clin North Am 27 2007 389 413
10. E. Romero Fernández, J.R. Pardo, A. Doyle, M.C. Albendea, and A.R. de la Rúa Hemophagocytic syndrome associated NK/T nasal type lymphoma presenting as hypereosinophilic syndrome: a case report and literature review Leuk Res 35 2011 e97 e99
11. F. Roufosse, A. de Lavareille, L. Schandené, E. Cogan, A. Georgelas, and L. Wagner Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome J Allergy Clin Immunol 26 2010 828 835.e3
12. C.M. Lilly, A. Churg, M. Lazarovich, R. Pauwels, L. Hendeles, and L.J. Rosenwasser Asthma therapies and Churg-Strauss syndrome J Allergy Clin Immunol 109 2002 S1 19
13. P. Stolk, M.J.C. Willemen, and H.G.M. Leufkens Rare essentials: drugs for rare diseases as essential medicines Bull World Health Organ 84 2006 745 751
14. R. Joppi, V. Bertele, and S. Garattini Orphan drug development is progressing too slowly Br J Clin Pharmacol 61 2006 355 360